Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
98.90    -1.20 (-1.20%)
Bid:
99.22
Ask:
99.28
Spread: 0.06 (0.06%)
Market Cap: £57.64b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Final Terms

14 Apr 2026 16:00

RNS Number : 4561A
Lloyds Banking Group PLC
14 April 2026
 

14 April 2026

Publication of Final Terms

The following Final Terms are available for viewing:

Final Terms dated 14 April 2026, for the £500,000,000 5.625 per cent. Fixed Rate Reset Dated Subordinated Tier 2 Notes due 2036 (the "Final Terms") (the "Notes") issued by Lloyds Banking Group plc pursuant to the base prospectus dated 23 March 2026 which constitutes a base prospectus (the "Prospectus") in connection with the £25,000,000,000 Euro Medium Term Note Programme established by Lloyds Banking Group plc.

The Final Terms for the Notes contain the final terms of the Notes. The Final Terms of the Notes must be read in conjunction with the Prospectus, which constitutes a base prospectus for the purposes of the PRM.

The expression "PRM" means the FCA Handbook Prospectus Rules: Admission to Trading on a Regulated Market sourcebook.

To view the full documents, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/4561A_1-2026-4-14.pdf

A copy of the Final Terms and the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

Investor Relations:

Douglas RadcliffeGroup Investor Relations DirectorTel: +44 (0) 20 7356 1571Email: douglas.radcliffe@lloydsbanking.com 

Group Corporate Affairs:

Matt SmithHead of Media RelationsTel: +44 (0) 7788 352 487Email: matt.smith@lloydsbanking.com

Lloyds Banking Group plcRegistered OfficeThe MoundEdinburgh EH1 1YZ

Disclaimer - Intended Addressees

Please note that the information contained in the Final Terms and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms or the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms or the Prospectus, you must ascertain from the Final Terms and/or the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

EU MiFID II/UK MiFIR (Product Governance) - professionals and ECPs-only / No EU PRIIPs KID or UK PRIIPs KID/CCI product summary - Manufacturer target market (EU MiFID II product governance and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No EU PRIIPs key information document (KID) or UK PRIIPs key information document (KID)/CCI product summary (as defined in the FCA Product Disclosure Sourcebook (DISC)) has been prepared as the Notes are not available to retail in the EEA or in the United Kingdom.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTUSVSRNWUSAAR
Date   Source Headline
2nd Mar 20266:04 pmRNSTransaction in Own Shares
2nd Mar 20264:25 pmRNSIssue of Equity
27th Feb 20266:00 pmRNSTransaction in Own Shares
27th Feb 20264:18 pmRNSTotal Voting Rights
27th Feb 20262:49 pmRNSPublication of a Supplementary Prospectus
27th Feb 20261:32 pmRNSPublication of a Supplementary Prospectus
26th Feb 20265:57 pmRNSTransaction in Own Shares
26th Feb 20262:58 pmRNS2025 Form 20F Filed
26th Feb 202611:57 amRNS2025 Annual Report and Accounts
26th Feb 202611:57 amRNS2025 Annual Report and Accounts
26th Feb 202611:57 amRNS2025 Annual Report and Accounts
25th Feb 20266:19 pmRNSTransaction in Own Shares
25th Feb 20269:00 amRNS2025 Annual Report and Accounts
24th Feb 20266:03 pmRNSTransaction in Own Shares
23rd Feb 20265:50 pmRNSTransaction in Own Shares
20th Feb 20266:05 pmRNSTransaction in Own Shares
19th Feb 20266:08 pmRNSTransaction in Own Shares
18th Feb 20266:09 pmRNSTransaction in Own Shares
17th Feb 20265:56 pmRNSTransaction in Own Shares
16th Feb 20265:59 pmRNSTransaction in Own Shares
16th Feb 20261:02 pmRNSPublication of a Supplementary Prospectus
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20261:52 pmRNS2025 Form 20F Filed
13th Feb 202610:32 amRNS2025 Annual Report and Accounts
12th Feb 20265:51 pmRNSTransaction in Own Shares
11th Feb 20265:56 pmRNSTransaction in Own Shares
11th Feb 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20265:54 pmRNSTransaction in Own Shares
10th Feb 20262:14 pmRNSPublication of Final Terms
9th Feb 20266:16 pmRNSTransaction in Own Shares
6th Feb 20266:04 pmRNSTransaction in Own Shares
5th Feb 20266:01 pmRNSTransaction in Own Shares
5th Feb 20262:00 pmRNSDirector/PDMR Shareholding
4th Feb 20266:07 pmRNSTransaction in Own Shares
3rd Feb 20266:16 pmRNSTransaction in Own Shares
2nd Feb 20266:25 pmRNSTransaction in Own Shares
30th Jan 20266:20 pmRNSTransaction in Own Shares
30th Jan 20263:18 pmRNSTotal Voting Rights
30th Jan 202611:30 amRNSPublication of a Supplementary Prospectus
30th Jan 20267:02 amRNSCommencement of Share Buyback Programme
29th Jan 202612:00 pmRNSBoard Committee Change
29th Jan 20267:00 amRNS2025 results
22nd Jan 202610:42 amRNSNotification of Redemption
19th Jan 20267:00 amRNSUpdate in respect of block listing of shares
13th Jan 20264:22 pmRNSDirector/PDMR Shareholding
2nd Jan 202610:00 amRNSBlock listing Interim Review
31st Dec 202511:00 amRNSTotal Voting Rights
31st Dec 202511:00 amRNSTotal Voting Rights
22nd Dec 20253:06 pmRNSDirector/PDMR Shareholding
22nd Dec 20253:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.